Braveheart Bio (BRVE) vs uniQure N.V. (QURE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Braveheart Bio is the larger company by market cap ($1.79 billion vs $1.57 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRVE | QURE |
|---|---|---|
| Share price | $19.88 | $22.59 |
| Market cap | $1.79B | $1.57B |
| 1-day change | +4.11% | +0.22% |
| YTD return | — | -5.81% |
| 1-year return | — | -62.41% |
| 5-year return | — | -25.02% |
| EPS (TTM) | $-6.08 | $-4.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $16.10M |
| Revenue growth (YoY) | — | -40.64% |
| Net income (latest FY) | — | $-198.97M |
| Gross margin | — | 89.53% |
| Operating margin | — | -1151.38% |
| Net margin | — | -1236.00% |
| 52-week high | $32.00 | $71.50 |
| 52-week low | $17.86 | $8.73 |
| Distance from 52-week high | -37.89% | -68.41% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +127.67% | +175.92% |
| Average volume | 558.38K | 1.97M |
| Shares outstanding | 90.04M | 69.37M |
| Employees | 49 | 221 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Braveheart Bio
BRVE stock →Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
About uniQure N.V.
QURE stock →uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees
BRVE vs QURE FAQ
Which is bigger, Braveheart Bio or uniQure N.V.?
Braveheart Bio (BRVE) is larger, with a market capitalization of $1.79B compared with $1.57B for uniQure N.V. (QURE).
Are Braveheart Bio and uniQure N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.